Afterdischarges in myotonic dystrophy type 1

Neurol Sci. 2024 Feb;45(2):735-740. doi: 10.1007/s10072-023-07013-2. Epub 2023 Aug 16.

Abstract

Objective: Electrodiagnostic testing is an important screening test for myotonic dystrophy type 1 (DM1). Although myotonic discharges are observed on electromyography in cases of DM1, it is difficult to distinguish DM1 from other myotonic disorders clinically. In the present study, afterdischarges, another type of pathological potential revealed by electrodiagnostic testing, were analyzed, and their role in distinguishing DM1 from other myotonic disorders was explored.

Methods: Data from 33 patients with myotonic discharges on electromyography were analyzed retrospectively. According to gene testing, the patients were divided into DM1 (n = 20) and non-DM1 myotonia (n = 13) groups. Afterdischarges were investigated by retrospectively evaluating the electrodiagnostic findings of motor nerve conduction studies, F-waves, and repetitive nerve stimulations.

Results: Afterdischarges were observed in 17 of the 20 patients with DM1, with an occurrence rate of approximately 85%. However, afterdischarges were absent in all patients with non-DM1 myotonia. There were significant differences in the occurrence rate between the two groups (P < 0.01).

Conclusion: Afterdischarges may serve as a suggestive role in clinical diagnosis of DM1. The discovery that DM1 can present with afterdischarges may pave a new way to study the pathogenesis of DM1.

Keywords: Afterdischarge; Electrodiagnostic testing; F-wave; Myotonic dystrophy; Repetitive nerve stimulation.

MeSH terms

  • Electromyography
  • Genetic Testing
  • Humans
  • Myotonia* / diagnosis
  • Myotonia* / genetics
  • Myotonic Dystrophy* / diagnosis
  • Myotonic Dystrophy* / genetics
  • Retrospective Studies